Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Identify buffer targets, automate savings, and simulate scenarios to ensure your budget remains steady when unexpected costs arise.
19,303 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Robinhood accelerates its blockchain push to compete with Coinbase, while Base narrows its focus to trading, payments...
As Citi gears up for its 2026 earnings call, investors need a clear view of the revenue mix, credit quality, and capi...
Shares FISERV rising today can reflect more than a quick swing. This article breaks down the catalysts, the business ...
FedEx filed a lawsuit seeking full refunds of IEEPA-era tariffs after a Supreme Court ruling restricted presidential ...
A closer look at dividend aristocrats with multi-decade payout streaks and what their steady income track means for i...
A new venture investor deploys a 360-degree behavioral map to evaluate founders, aiming to separate truly resilient t...
SDNY prosecutors seek a new trial for Tornado Cash co-founder Roman Storm in October 2026, even as U.S. agencies ackn...
Many savers depend on one retirement account, assuming it will carry them through. This article shows why that mindse...
Oil hovers above $100 as the U.S. weighs a potential ground war in Iran. The move could ripple through gas prices, in...
A big investor recently unloaded $7.8 million worth of Harrow stock. This article breaks down whether that move signa...
When insiders sell, investors watch closely. This article unpacks a recent move at Laureate Education and translates ...